EGFR status and expression of downstream kinases in colorectal tumors and metastatic sites

被引：0
|
作者：
不详
机构：
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2007年 / 4卷 / 11期
关键词：
D O I：
10.1038/ncponc0913
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：616 / 616
页数：1
相关论文
共 50 条
  • [1] EGFR status and expression of downstream kinases in colorectal tumors and metastatic sites
    Nature Clinical Practice Oncology, 2007, 4 : 616 - 616
  • [2] Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites:: biological and clinical implications
    Italiano, A
    Saint-Paul, MC
    Caroli-Bosc, FX
    François, E
    Bourgeon, A
    Benchimol, D
    Gugenheim, J
    Michiels, JF
    ANNALS OF ONCOLOGY, 2005, 16 (09) : 1503 - 1507
  • [3] Epidermal growth factor receptor (EGFR) downstream signaling pathway in primary colorectal tumors and related metastatic sites: Optimizing EGFR targeted treatment options
    Scartozzi, M.
    Bearzi, I
    Berardi, R.
    Mandolesi, A.
    Pierantoni, C.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2006, 17 : XI27 - XI27
  • [4] Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: Implications for treatment with EGFR-targeted monoclonal antibodies
    Scartozzi, M
    Bearzi, I
    Berardi, R
    Mandolesi, A
    Fabris, G
    Cascinu, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) : 4772 - 4778
  • [5] EGFR expression variance in paired colorectal cancer primary and metastatic tumors
    Yarom, Nirit
    Marginean, Celia
    Moyana, Terence
    Gorn-Hondermann, Ivan
    Birnboim, H. Chaim
    Marginean, Horia
    Auer, Rebecca C.
    Vickers, Michael
    Asmis, Timothy R.
    Maroun, Jean
    Jonker, Derek
    CANCER BIOLOGY & THERAPY, 2010, 10 (05) : 416 - 421
  • [6] EGFR downstream signaling pathway in primary colorectal tumours and related metastatic sites: optimizing EGFR targeted treatment options
    Scartozzi, M.
    Bearzi, I.
    Berardi, R.
    Mandolesi, A.
    Pierantoni, C.
    Cascinu, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 186 - 186
  • [7] KRAS MUTATIONAL STATUS IN PRIMARY COLORECTAL TUMORS AND MATCHED METASTATIC SITES: IMPLICATIONS FOR TREATMENT WITH ANTI-EGFR MONOCLONAL ANTIBODIES
    Italiano, A.
    Fabas, T.
    Keslair, F.
    Caroli, F.
    Francois, E.
    Benchimol, D.
    Gugenheim, J.
    Saint-Paul, M.
    Pedeutour, F.
    ANNALS OF ONCOLOGY, 2008, 19 : 126 - 126
  • [8] Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant
    Molinari, F.
    Martin, V.
    Saletti, P.
    De Dosso, S.
    Spitale, A.
    Camponovo, A.
    Bordoni, A.
    Crippa, S.
    Mazzucchelli, L.
    Frattini, M.
    BRITISH JOURNAL OF CANCER, 2009, 100 (07) : 1087 - 1094
  • [9] Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant
    F Molinari
    V Martin
    P Saletti
    S De Dosso
    A Spitale
    A Camponovo
    A Bordoni
    S Crippa
    L Mazzucchelli
    M Frattini
    British Journal of Cancer, 2009, 100 : 1087 - 1094
  • [10] Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti-EGFR antibodies in colorectal cancer
    Perkins, Geraldine
    Lievre, Astrid
    Ramacci, Carole
    Meatchi, Tchao
    de Reynies, Aurelien
    Emile, Jean-Francois
    Boige, Valerie
    Tomasic, Gorana
    Bachet, Jean-Baptiste
    Bibeau, Frederic
    Bouche, Olivier
    Penault-Llorca, Frederique
    Merlin, Jean-Louis
    Laurent-Puig, Pierre
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (06) : 1321 - 1331
12345